RLAY - Relay Therapeutics Inc
IEX Last Trade
6.8
0.040 0.588%
Share volume: 1,166,761
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.76
0.04
0.59%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-03 | 2023-02-23 | 2023-05-04 | 2023-08-08 | 2023-11-02 | 2024-02-22 | 2024-05-02 | |
| Total revenue | 365.000 K | 344.000 K | 253.000 K | 226.000 K | 119.000 K | 25.202 M | -1.000 K | 10.007 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 365.000 K | 344.000 K | 253.000 K | 226.000 K | 119.000 K | 25.202 M | -1.000 K | 10.007 M | |
| -5.75% | -26.45% | -10.67% | -47.35% | 21,078.15% | -100.00% | 1,000,800.00% | |||
| Operating expenses | 77.976 M | 82.974 M | 83.648 M | 102.406 M | 108.321 M | 99.979 M | 94.262 M | 102.202 M | |
| Selling general and admin | 17.465 M | 16.074 M | 16.371 M | 19.579 M | 20.120 M | 18.485 M | 16.766 M | 19.799 M | |
| Research and development | 60.511 M | 66.900 M | 67.277 M | 82.827 M | 88.201 M | 81.494 M | 77.496 M | 82.403 M | |
| Total expenses | 77.976 M | 82.974 M | 83.648 M | 102.406 M | 108.321 M | 99.979 M | 94.262 M | 102.202 M | |
| 6.41% | 0.81% | 22.42% | 5.78% | -7.70% | -5.72% | 8.42% | |||
| Operating income | -77.611 M | -82.630 M | -83.395 M | -102.180 M | -108.202 M | -74.777 M | -94.263 M | -92.195 M | |
| Ebit | -77.611 M | -82.630 M | -83.395 M | -102.180 M | -108.202 M | -74.777 M | -94.263 M | -92.195 M | |
| Pretax income | -76.788 M | -84.172 M | -67.503 M | -94.239 M | -98.505 M | -65.734 M | -83.495 M | -81.387 M | |
| 9.62% | -19.80% | 39.61% | 4.53% | -33.27% | 27.02% | -2.52% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -76.788 M | -84.172 M | -67.503 M | -94.239 M | -98.505 M | -65.734 M | -83.495 M | -81.387 M | |
| -9.62% | 19.80% | -39.61% | -4.53% | 33.27% | -27.02% | 2.52% | |||
| Net income | -76.788 M | -84.172 M | -67.503 M | -94.239 M | -98.505 M | -65.734 M | -83.495 M | -81.387 M | |
| -9.62% | 19.80% | -39.61% | -4.53% | 33.27% | -27.02% | 2.52% |